The incidence of arrhythmias during exercise stress tests among children with Kawasaki disease: A single‐center case series

Aggarwal, Varun; Sexson‐Tejtal, Kristen; Lam, Wilson; Valdés, Santiago O.; Uz, Caridad M. de la; Kim, Jeffrey; Miyake, Christina Y.

doi:10.1111/chd.12864

Cited by 4 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study of 165 patients with a history of KD using exercise stress testing showed that ventricular arrhythmias were uncommon and were seen only in patients with medium or large CALs [46]. This finding was consistent with the findings of the present study.…”

Section: Discussionsupporting

confidence: 92%

Acute Phase Treatment and Medium-Term Outcomes in Kawasaki Disease

Nakada

2020

EJMED

View full text Add to dashboard Cite

An acute phase treatment for prevention of coronary artery stenosis caused by Kawasaki disease (KD) has not been established. The objective of this study was to clarify the medium-term outcomes of patients who received acute phase treatment in our department. This retrospective study included data from 214 patients with KD who received acute phase treatment from January 2009 to May 2020. A total of 196 (92.1%) received an initial single dose of intravenous immunoglobulin (IVIG) therapy. One patient with status epilepticus at presentation received initial IVIG plus steroid therapy. A total of 17 patients did not receive IVIG. The rate of coronary artery lesions (CALs) 1 month and 1 year after KD onset were 1.9% and 0.9%, respectively. Two patients had CAL 1 year after KD onset. However, no patients had coronary artery stenosis. One patient with a right giant CAL had a medium CAL before initial therapy. During a median follow-up period of 3 years and 4 months, no patients had cardiac events that required therapy.

show abstract

Section: Discussionsupporting

confidence: 92%

Acute Phase Treatment and Medium-Term Outcomes in Kawasaki Disease

Nakada

2020

EJMED

View full text Add to dashboard Cite

show abstract

Cardiac Concerns in the Pediatric Athlete

Colombo

Sawda

White

2022

Clinics in Sports Medicine

View full text Add to dashboard Cite

Diretriz Brasileira de Ergometria em Crianças e Adolescentes – 2024

Carvalho,

Freitas,

Chalela

et al. 2024

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

Classes de Recomendação Classe I: Condições para as quais há evidências conclusivas e, na sua falta, consenso geral de que o procedimento é seguro e útil/eficaz. Classe II: Condições para as quais há evidências conflitantes e/ou divergência de opinião sobre a segurança e utilidade/eficácia do procedimento. Classe IIa: Peso ou evidência/opinião a favor do procedimento. A maioria aprova. Classe IIb: Segurança e utilidade/eficácia menos estabelecidas, havendo opiniões divergentes. Classe III: Condições para as quais há evidências e/ou consenso de que o procedimento não é útil/eficaz e, em alguns casos, pode ser prejudicial. Níveis de Evidência Nível A: Dados obtidos a partir de múltiplos estudos randomizados de bom porte, concordantes e/ou de metanálise robusta de estudos randomizados. Nível B: Dados obtidos a partir de metanálise menos robusta, a partir de um único estudo randomizado e/ou de estudos observacionais. Nível C: Dados obtidos de opiniões consensuais de especialistas.

show abstract

The incidence of arrhythmias during exercise stress tests among children with Kawasaki disease: A single‐center case series

Cited by 4 publications

References 12 publications

Acute Phase Treatment and Medium-Term Outcomes in Kawasaki Disease

Acute Phase Treatment and Medium-Term Outcomes in Kawasaki Disease

Cardiac Concerns in the Pediatric Athlete

Diretriz Brasileira de Ergometria em Crianças e Adolescentes – 2024

Contact Info

Product

Resources

About